Recombinant Human Relaxin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Recombinant Human Relaxin, covering 2008-06-25 to 2014-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor [Phase 2]